|
US2004072757A1
|
|
Agents affecting thrombosis and hemostasis
|
|
US2003228307A1
|
|
Inhibitory immunoglobulin polypeptides to human PDGF beta receptor
|
|
AU1868102A
|
|
Identification of Bap-1, a protein that binds to integrin and is involved in integrin-mediated signal transduction
|
|
JP2002234899A
|
|
Recombinant medicine acting on thrombosis
|
|
AU9713401A
|
|
Heterocyclic derivatives as factor Xa inhibitors
|
|
AU3927702A
|
|
Adenine based inhibitors of adenylyl cyclase, pharmaceutical compositions and method of use thereof
|
|
AU1799902A
|
|
Nitrogenous heterocyclic compounds and process for making nitrogenous heterocyclic compounds and intermediates thereof
|
|
AU1462602A
|
|
Quaternary amines and related inhibitors of factor xa
|
|
AU1128002A
|
|
Piperazin-2-one amides as inhibitors of factor xa
|
|
AU1454602A
|
|
Bicyclic pyrimidin-4-one based inhibitors of factor xa
|
|
AU1128102A
|
|
Quaternary amidino based inhibitors of factor xa
|
|
AU8690001A
|
|
Therapeutics and diagnostics based on a novel signal transduction system in platelets
|
|
WO0216361A2
|
|
Nitrogenous heterocyclic compounds
|
|
WO0216362A2
|
|
Nitrogenous heterocyclic compounds
|
|
WO0216360A2
|
|
Nitrogenous heterocyclic compounds
|
|
AU2293302A
|
|
Inhibitors of factor Xa
|
|
AU6846101A
|
|
Uncoupling proteins as targets for the treatment of heart failure
|
|
AU6664201A
|
|
Methods for producing amino substituted chromanes and intermediates thereof
|
|
AU6816601A
|
|
Chiral and achiral synthesis of 2-acyl substituted chromanes and their derivatives
|
|
WO0192250A2
|
|
Synthesis of 2-acyl substituted chromanes and intermediates thereof
|
